These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20922813)

  • 21. cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
    Chittasupho C; Manikwar P; Krise JP; Siahaan TJ; Berkland C
    Mol Pharm; 2010 Feb; 7(1):146-55. PubMed ID: 19883077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of mZD7349-conjugated PLGA nanoparticles for selective targeting of vascular cell-adhesion molecule-1 in inflamed endothelium.
    Imanparast F; Paknejad M; Faramarzi MA; Kobarfard F; Amani A; Doosti M
    Microvasc Res; 2016 Jul; 106():110-6. PubMed ID: 27105996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid.
    Keum CG; Noh YW; Baek JS; Lim JH; Hwang CJ; Na YG; Shin SC; Cho CW
    Int J Nanomedicine; 2011; 6():2225-34. PubMed ID: 22114486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity.
    Yan F; Zhang C; Zheng Y; Mei L; Tang L; Song C; Sun H; Huang L
    Nanomedicine; 2010 Feb; 6(1):170-8. PubMed ID: 19447200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
    Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
    Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E; Park J; Yeo Y
    Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling of nanoparticle transport through the female reproductive tract for the treatment of infectious diseases.
    Sims LB; Miller HA; Halwes ME; Steinbach-Rankins JM; Frieboes HB
    Eur J Pharm Biopharm; 2019 May; 138():37-47. PubMed ID: 30195726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles using sodium carboxymethyl cellulose as colloidal stabilize.
    Chittasupho C; Thongnopkoon T; Kewsuwan P
    Curr Drug Deliv; 2016; 13(1):95-104. PubMed ID: 26338259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles.
    Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A
    J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.
    Imanparast F; Faramarzi MA; Vatannejad A; Paknejad M; Deiham B; Kobarfard F; Amani A; Doosti M
    Microvasc Res; 2017 Jul; 112():14-19. PubMed ID: 28161429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the Effect of Surface Hydrophilicity on the Destiny of PLGA-Poloxamer Nanoparticles in an In Vivo Animal Model.
    Silvestri T; Grumetto L; Neri I; De Falco M; Graziano SF; Damiano S; Giaquinto D; Maruccio L; de Girolamo P; Villapiano F; Ciarcia R; Mayol L; Biondi M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of binding and internalization of ICAM-1-derived cyclic peptides by LFA-1 on the surface of T cells: a potential method for targeted drug delivery.
    Anderson ME; Siahaan TJ
    Pharm Res; 2003 Oct; 20(10):1523-32. PubMed ID: 14620502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M; Misra R; Harilal A; Sahoo SK; Krishnakumar S
    Mol Vis; 2011; 17():2724-37. PubMed ID: 22065926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.
    Fields RJ; Quijano E; McNeer NA; Caputo C; Bahal R; Anandalingam K; Egan ME; Glazer PM; Saltzman WM
    Adv Healthc Mater; 2015 Feb; 4(3):361-6. PubMed ID: 25156908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
    J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
    Betancourt T; Byrne JD; Sunaryo N; Crowder SW; Kadapakkam M; Patel S; Casciato S; Brannon-Peppas L
    J Biomed Mater Res A; 2009 Oct; 91(1):263-76. PubMed ID: 18980197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.